A degradation product of mitragynine that appears post-harvest is 7-hydroxymitragynine (7-OH). Mitragynine is a partial ...
Georgia's ruling party is set to beat the pro-Western opposition in a closely watched legislative election, according to partial results that indicated a new setback to the Caucasus country's bid ...
AST-004 is a small-molecule adenosine A1/A3 receptor agonist that has exhibited significant cerebroprotective efficacy in preclinical models of acute ischemic stroke and traumatic brain injury. The ...
A new class of drugs is set to join their ranks and has the potential to eclipse them all—GLP-1 receptor agonists. These drugs mimic the action of a naturally occurring hormone, glucagon-like ...
Toll-like receptors (TLRs) and their signalling pathways have therapeutic potential for the treatment of inflammation, cancer, infection, allergy and autoimmunity. The elucidation of the structure ...
About The Study: Prescribing for both glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter 2 (SGLT2) inhibitors in a type 1 diabetes (T1D) population identified in ...
Credit: fcm82 / Shutterstock. On October 21, Novo Nordisk announced positive news on the cardiovascular benefits of its oral glucagon-like peptide-1 receptor (GLP-1R) agonist, Rybelsus, which is ...
Structure Therapeutics Inc. (NASDAQ:GPCR) was able to report positive results from its phase 2a study using its GLP-1R agonist GSBR-1290 for the treatment of patients with obesity in June 2024.
A research team led by Prof. Zhou Rongbin from the University of Science and Technology of China (USTC) discovered the mechanism by which lysophosphatidylserine (LysoPS) inhibits the anti-tumor ...
Partial Withdrawal After 5 years of account activation Can withdraw up to 50% of the amount at the end of the 4th year preceding the withdrawal year None Premature Withdrawal After 5 years of ...
The Deadline: Legal Newsletter looks at requests from Michael Cohen and Michael Avenatti as the court wrapped up its October arguments. By Jordan Rubin Welcome back, Deadline: Legal Newsletter ...